{"id":1253,"date":"2022-07-27T10:22:30","date_gmt":"2022-07-27T01:22:30","guid":{"rendered":"https:\/\/fgb.tamagawa-seiki.com\/english\/?post_type=technology&#038;p=1253"},"modified":"2022-08-24T15:10:23","modified_gmt":"2022-08-24T06:10:23","slug":"n-iwamoto-et-al-2016","status":"publish","type":"technology","link":"https:\/\/fgb.tamagawa-seiki.com\/english\/technology\/n-iwamoto-et-al-2016","title":{"rendered":"N. Iwamoto et al.(2016) [nSMOL]"},"content":{"rendered":"<p><a href=\"https:\/\/www.omicsonline.org\/open-access\/multiplex-lcms-bioanalysis-of-brentuximab-vedotin-rituximab-and-cetuximab-towards-therapeutic-drug-monitoring-application-by-combi-2167-065X-1000164.php?aid=79879\" target=\"_blank\" rel=\"noopener noreferrer\">Multiplex LCMS Bioanalysis of Brentuximab Vedotin, Rituximab and Cetuximab towards Therapeutic Drug Monitoring Application by Combined Calibration Curve Using Fab-Selective Limited Proteolysis nSMOL<\/a><br \/>\nClin Pharmacol Biopharm 2016, 5:4<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology\/1253"}],"collection":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology"}],"about":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/types\/technology"}],"wp:attachment":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/media?parent=1253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}